Special items: Ovarian Cancer and Us blog best viewed in Firefox

Thursday, December 31, 2009

Identifying novel autoantibody signatures in ovarian cancer

CONCLUSIONS: Protein microarrays are suitable for autoantibody discovery in ovarian cancer but the signatures are of low frequency.

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.